EUVIMEDEUVIMED entdecken
Leserbrief

The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series

Xin-Yi Li iD, Fang-Yang Jiao, Rui-Xin Yao, Zi-Zhao Ju, Ming-Jia Chen, Jing-Jie Ge, Gen Li iD, Yi-Min Sun, Ping Wu, Jian-Jun Wu, Tzu-Chen Yen, Chuantao Zuo iD und 4 weitere

Movement Disorders · 2023

DOI: 10.1002/mds.29328 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Movement Disorders, 2023. Verfasst von Xin-Yi Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Med…. Hauptthemen laut MEDLINE: Selegiline, Supranuclear Palsy, Progressive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SelegilineSupranuclear Palsy, ProgressiveHumansMonoamine Oxidase Inhibitorstau ProteinsMonoamine OxidasePositron-Emission Tomography

Stichwörter der Autor:innen

18F-Florzolotaumonoamine oxidase Bpositron emission tomographyselegilinetau

Substanzen

SelegilineMonoamine Oxidase Inhibitorstau ProteinsMonoamine Oxidase

Autor:innen und Institutionen

  • Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Nuclear Medicine & PET Center, National Center for Neurological Disorders, and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
  • APRINOIA Therapeutics, Suzhou, China.

ORCID-Profile: Xin-Yi Li, Gen Li, Chuantao Zuo, Jian Wang, Jia-Ying Lu, Feng-Tao Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X. Y., Jiao, F. Y., Yao, R. X., Ju, Z. Z., Chen, M. J., Ge, J. J., Li, G., Sun, Y. M., Wu, P., Wu, J. J., Yen, T. C., Zuo, C., Wang, J., Lu, J. Y., Liu, F. T., & Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI) (2023). The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series. Movement Disorders. https://doi.org/10.1002/mds.29328

Vancouver

Li XY, Jiao FY, Yao RX, Ju ZZ, Chen MJ, Ge JJ, et al. The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series. Movement Disorders. 2023. doi:10.1002/mds.29328

BibTeX
@article{Li2023,
  author = {Li, Xin-Yi and Jiao, Fang-Yang and Yao, Rui-Xin and Ju, Zi-Zhao and Chen, Ming-Jia and Ge, Jing-Jie and Li, Gen and Sun, Yi-Min and Wu, Ping and Wu, Jian-Jun and Yen, Tzu-Chen and Zuo, Chuantao and Wang, Jian and Lu, Jia-Ying and Liu, Feng-Tao and Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI), Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)},
  title = {The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series},
  journal = {Movement Disorders},
  year = {2023},
  doi = {10.1002/mds.29328}
}
Kostenlos starten →